[A 1-year experience with the administration of clopenthixol decanoate in schizophrenic psychoses]. 1984

J Svestka, and K Náhunek, and E Cesková, and R Rysánek

UI MeSH Term Description Entries
D008297 Male Males
D003006 Clopenthixol A thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors. Cisordinol,Zuclopenthixol,alpha-Clopenthixol,alpha Clopenthixol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D013892 Thioxanthenes Compounds with three aromatic rings in linear arrangement with a SULFUR in the center ring.
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

J Svestka, and K Náhunek, and E Cesková, and R Rysánek
August 1986, Ceskoslovenska psychiatrie,
J Svestka, and K Náhunek, and E Cesková, and R Rysánek
January 1982, Pharmatherapeutica,
J Svestka, and K Náhunek, and E Cesková, and R Rysánek
November 1998, Fortschritte der Neurologie-Psychiatrie,
J Svestka, and K Náhunek, and E Cesková, and R Rysánek
January 1981, Current medical research and opinion,
J Svestka, and K Náhunek, and E Cesková, and R Rysánek
January 1968, Neuropsihijatrija,
J Svestka, and K Náhunek, and E Cesková, and R Rysánek
January 1980, Acta psychiatrica Scandinavica. Supplementum,
J Svestka, and K Náhunek, and E Cesková, and R Rysánek
November 1979, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
J Svestka, and K Náhunek, and E Cesková, and R Rysánek
August 1977, Acta pharmacologica et toxicologica,
J Svestka, and K Náhunek, and E Cesková, and R Rysánek
January 1984, Pharmatherapeutica,
J Svestka, and K Náhunek, and E Cesková, and R Rysánek
September 1972, Acta psychiatrica Belgica,
Copied contents to your clipboard!